IRUS-ANZ has moved. From January 2022, new monthly statistics will only be added to the IRUS R5 service. This site is archived. All statistics up to December 2021 will remain available on this site.
Item Statistics
Raltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: A randomised open label study for the treatment of HIV-1 infection
Repository | University of Queensland [UQ eSpace] |
URL | https://espace.library.uq.edu.au/view/UQ:512223 |
Author(s) | Amin, Janaki; Boyd, Mark A.; Kumarasamy, Nagalingeswaran; Moore, Cecilia L.; Losso, Marcello H.; Nwizu, Chidi A.; Mohapi, Lerato; Kerr, Stephen J.; Sohn, Annette H.; Teppler, Hedy; Renjifo, Boris; Molina, Jean-Michel; Emery, Sean; Cooper, David A. |
Item type | Article |
DOI | https://doi.org/10.1371/journal.pone.0118228 |